Final Flashcards
(251 cards)
What are the 2 global governing bodies responsible for molding our understanding, evaluation, and treatment of asthma?
GINA - Global Initiative for Asthma
NAEPP - National Asthma Education and Prevention Program
Describe GINA
Global Initiative for Asthma
Global in scope
Comprehensive guidelines for children and adults
Annual updates
Describe NAEPP
National Asthma Education and Prevention Program
National in scope
Comprehensive guidelines for children and adults
Updates annually
Why is it difficult to diagnose asthma?
Differing definitions
Differing manifestations, triggers, intensities ect
Subtypes of the disease are defined differently by different authorities
What is the GINA definition of asthma?
Asthma is a heterogeneous disease usually characterized by chronic airway inflammation
What airway characteristics are usually associated with asthma?
Airway hyperresponsiveness
Airway inflammation
What symptoms does GINA say define asthma?
Wheeze, shortness of breath, chest tightness, and cough that vary over time and intensity
Together with variable expiratory airflow limitation
Where does asthma lie on the dyspnea pyramid?
Bottom, lungs
Airways
What are asthma phenotypes?
Recognizable clusters of demographic, clinical or pathological characteristics
Keep in mind that these do not correlate strongly with specific pathological processes or treatment responses
What are the “Big Six” categories that encompass disease management?
Presentation
Definition
Epidemiology
Etiology/pathophysiology
Diagnosis
Management
What are questions you should be thinking about when considering patient presentation?
What does the patient look like coming through the door?
What are characteristic signs and symptoms
What history of present illness do we see?
What are the clinical manifestations that we can observe?
What is the difference between a definition of a disease and a diagnosis of a disease?
A definition defines what the disease is
Diagnosis is confirming that the patient has the disease
When considering the rarity, occurrence, and populations at risk for a disease, what category are we considering?
Epidemiology
What questions should we be asking when considering the epidemiology of a disease?
Is the condition common or rare?
Is this condition seen frequently? Rarely?
Does this conditions appearance correlate to a season?
What populations are at risk for this disease?
If we are thinking about the disease in regards to its frequency, seasonal correlation, and affected populations, we are thinking about the diseases
Epidemiology
When we are studying how a disease develops, what conditions lead to the disease and how the disease sabotages the body, we are discussing…
Etiology or pathophysiology
When considering pathophysiology, we must consider the following questions
How does the disease develop
What conditions give rise to the disease
How does the disease sabotage your body?
Give an example of how incidence can be communicated
How many new cases per hundred thousand people in the country/state/region over a year
In some cases it can be how many new cases per state per day, like with COVID
Define incidence in relation to epidemiology
How many new cases in a given number in a given population in a given length of time
What questions must we ask when attempting to diagnose a disease?
How do we confirm the presence of the disease
What are the appropriate tests to conduct to determine the presence of the disease?
What testing will help us isolate this condition as the patients root problem and rule out other problems?
Define prevalence in relation to epidemiology
How many people in the population have the condition
How would one select tests in order to diagnose a disease
Assess clinical manifestations
Consider typical tests and what they might reveal
ABG
Pulmonary function tests
Lab tests
Chest imaging
Survey the tests AVAILABLE and select the tests LIKELY TO BE PRODUCTIVE
We cant test everyone for everything
What is the prevalence of asthma?
7.8% in 2020
Why do we need to be thoughtful with our test selection?
Some tests will not give us useful information ie an STD panel when the patient has asthma
Want to eliminate the potential for false positives, the more tests run, the higher the chances are that a test is done incorrectly
Erroneous tests? IN THIS ECONOMY??